Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | английский |
Опубликовано: |
2018
|
Online-ссылка: | https://doi.org/10.1016/j.ymthe.2018.06.008 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|